EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

An ‘Adaptive Treatment Strategy’ for Oral Vancomycin in Patients with the Orphan Disease Primary Sclerosing Cholangitis

Ayesha Shah, James Tabibian, Cynthia Buness, Gerald J Holtmann

Digestive Diseases and Sciences · 2024-10 · 69 (10) · 3608-3613

DOI: 10.1007/s10620-024-08497-4 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Digestive Diseases and Sciences, online erschienen am 19.06.2024. Verfasst von Ayesha Shah und 3 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, The University of Queensland, Brisbane, Australia. Hauptthemen laut MEDLINE: Cholangitis, Sclerosing, Rare Diseases, Vancomycin, Anti-Bacterial Agents. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Health and Medical Research Council, The University of Queensland.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cholangitis, SclerosingRare DiseasesVancomycinAnti-Bacterial AgentsHumansAdministration, OralQuality of Life

Stichwörter der Autor:innen

Adaptive treatment strategyOral vancomycinOrphan diseasePrimary sclerosing cholangitisRare diseaseTherapeutic decision-making

Substanzen

VancomycinAnti-Bacterial Agents

Autor:innen und Institutionen

  • Faculty of Medicine, The University of Queensland, Brisbane, Australia.
  • Department of Gastroenterology & Hepatology, Princess Alexandra Hospital, Brisbane, QLD, Australia.
  • David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.
  • Adventist Health Glendale Medical Center, Glendale, CA, USA.
  • Global Liver Institute Pediatric and Rare Liver Diseases Research Working Group, Washington, DC, USA.
  • Autoimmune Liver Disease Network for Kids (A-LiNK), Stanford University, Palo Alto, CA, USA.

Förderung

  • National Health and Medical Research Council
  • The University of Queensland

Zitieren

APA

Shah, A., Tabibian, J., Buness, C., & Holtmann, G. J. (2024). An ‘Adaptive Treatment Strategy’ for Oral Vancomycin in Patients with the Orphan Disease Primary Sclerosing Cholangitis. Digestive Diseases and Sciences, 69(10), 3608-3613. https://doi.org/10.1007/s10620-024-08497-4

Vancouver

Shah A, Tabibian J, Buness C, Holtmann GJ. An ‘Adaptive Treatment Strategy’ for Oral Vancomycin in Patients with the Orphan Disease Primary Sclerosing Cholangitis. Digestive Diseases and Sciences. 2024;69(10):3608-3613. doi:10.1007/s10620-024-08497-4

BibTeX
@article{Shah2024,
  author = {Shah, Ayesha and Tabibian, James and Buness, Cynthia and Holtmann, Gerald J},
  title = {An ‘Adaptive Treatment Strategy’ for Oral Vancomycin in Patients with the Orphan Disease Primary Sclerosing Cholangitis},
  journal = {Digestive Diseases and Sciences},
  year = {2024},
  volume = {69},
  number = {10},
  pages = {3608--3613},
  doi = {10.1007/s10620-024-08497-4}
}
Kostenlos starten →